Pharmacology of Cognition in Schizotypal Personality

ID Number 95-0650

Principal Investigator(s)
Larry J Siever

Department(s) or Division(s)


The purpose of this study is to examine the effects of the administration of a drug called GUANFACINE (Tenex) on attention, concentration, memory and motivation in persons with schizotypal personality disorder (SPD). This drug is approved for the treatment of high blood pressure but is not currently approved for use in schizotypal personality disorder.

Contact Information
Ayelet Boussi
(212) 241-4459

Recruiting Patients: Yes